$ACTG
ACACIA RESEARCH CORP Stock $actg

$actg Overview Financials Valuation SEC Filings Company Website

2015 Q1 Form 10-Q Financial Statement

#000093454915000013 Filed on May 06, 2015

Income Statement

Concept	2015 Q1	2014 Q1
Revenue	$34.21M	$12.58M
YoY Change	171.98%	-83.64%
Cost Of Revenue	$9.330M	$950.0K
YoY Change	882.11%	-94.86%
Gross Profit	$24.89M	$11.63M
YoY Change	114.02%	-80.08%
Gross Profit Margin	72.76%	92.46%
Selling, General & Admin	$15.36M	$13.22M
YoY Change	16.19%	-54.22%
% of Gross Profit	61.71%	113.67%
Research & Development	$1.000M	$990.0K
YoY Change	1.01%	-2.94%
% of Gross Profit	4.02%	8.51%
Depreciation & Amortization	$13.10M	$14.55M
YoY Change	-9.97%	23.59%
% of Gross Profit	52.64%	125.12%
Operating Expenses	$29.81M	$28.69M
YoY Change	3.9%	-31.1%
Operating Profit	-$13.61M	-$26.05M
YoY Change	-47.76%	-467.17%
Interest Expense		$110.0K
YoY Change		-91.47%
% of Operating Profit
Other Income/Expense, Net	$228.0K	$109.0K
YoY Change	109.17%	-91.55%
Pretax Income	-$13.38M	-$25.94M
YoY Change	-48.42%	-409.39%
Income Tax	$170.0K	-$1.372M
% Of Pretax Income
Net Earnings	-$13.13M	-$24.42M
YoY Change	-46.23%	-577.63%
Net Earnings / Revenue	-38.38%	-194.16%
Basic Earnings Per Share	-$0.27	-$0.51
Diluted Earnings Per Share	-$0.27	-$0.51
COMMON SHARES
Basic Shares Outstanding	49.21M shares	48.33M shares
Diluted Shares Outstanding	49.21M shares	48.33M shares

Balance Sheet

Concept	2015 Q1	2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$154.8M	$229.0M
YoY Change	-32.4%	-30.05%
Cash & Equivalents	$101.5M	$146.0M
Short-Term Investments	$53.30M	$95.60M
Other Short-Term Assets	$17.00M	$10.70M
YoY Change	58.88%	109.8%
Inventory
Prepaid Expenses
Receivables	$30.01M	$13.54M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$201.8M	$253.3M
YoY Change	-20.34%	-32.97%
LONG-TERM ASSETS
Property, Plant & Equipment	$421.0K	$782.0K
YoY Change	-46.16%	45.9%
Goodwill	$30.15M	$30.15M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$355.0K	$309.0K
YoY Change	14.89%	123.91%
Total Long-Term Assets	$305.6M	$321.4M
YoY Change	-4.93%	-4.51%
TOTAL ASSETS
Total Short-Term Assets	$201.8M	$253.3M
Total Long-Term Assets	$305.6M	$321.4M
Total Assets	$507.4M	$574.7M
YoY Change	-11.72%	-19.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.70M	$12.30M
YoY Change	3.25%	-28.07%
Accrued Expenses	$900.0K	$19.30M
YoY Change	-95.34%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$32.73M	$35.44M
YoY Change	-7.64%	-34.2%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$250.0K	$319.0K
YoY Change	-21.63%	-35.43%
Total Long-Term Liabilities	$250.0K	$319.0K
YoY Change	-21.63%	-35.43%
TOTAL LIABILITIES
Total Short-Term Liabilities	$32.73M	$35.44M
Total Long-Term Liabilities	$250.0K	$319.0K
Total Liabilities	$34.15M	$39.51M
YoY Change	-13.57%	-51.93%
SHAREHOLDERS EQUITY
Retained Earnings	-$141.2M	-$86.49M
YoY Change	63.29%	16564.16%
Common Stock	$51.00K	$50.00K
YoY Change	2.0%	2.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$34.64M	$34.64M
YoY Change	0.0%	29.59%
Treasury Stock Shares	1.729M shares	1.729M shares
Shareholders Equity	$468.2M	$528.9M
YoY Change
Total Liabilities & Shareholders Equity	$507.4M	$574.7M
YoY Change	-11.72%	-19.57%

Cashflow Statement

Concept	2015 Q1	2014 Q1
OPERATING ACTIVITIES
Net Income	-$13.13M	-$24.42M
YoY Change	-46.23%	-577.63%
Depreciation, Depletion And Amortization	$13.10M	$14.55M
YoY Change	-9.97%	23.59%
Cash From Operating Activities	-$15.83M	-$20.43M
YoY Change	-22.52%	-221.44%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$96.00K
YoY Change	-100.0%	-60.17%
Acquisitions
YoY Change
Other Investing Activities	$5.200M	$34.40M
YoY Change	-84.88%	-178.18%
Cash From Investing Activities	-$11.65M	$33.32M
YoY Change	-134.97%	-169.1%
FINANCING ACTIVITIES
Cash Dividend Paid	$6.375M	$6.255M
YoY Change	1.92%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$5.437M	-$6.165M
YoY Change	-11.81%	-324.51%
NET CHANGE
Cash From Operating Activities	-$15.83M	-$20.43M
Cash From Investing Activities	-$11.65M	$33.32M
Cash From Financing Activities	-$5.437M	-$6.165M
Net Change In Cash	-$32.92M	$6.718M
YoY Change	-590.0%	-123.45%
FREE CASH FLOW
Cash From Operating Activities	-$15.83M	-$20.43M
Capital Expenditures	$0.00	$96.00K
Free Cash Flow	-$15.83M	-$20.53M
YoY Change	-22.89%	-223.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q4	actg	Accrued Patent Acquisition Related Payments Current AccruedPatentAcquisitionRelatedPaymentsCurrent	16700000	USD
CY2015Q1	actg	Accrued Patent Acquisition Related Payments Current AccruedPatentAcquisitionRelatedPaymentsCurrent	900000	USD
CY2014Q1	actg	Contingent Legal Fees ContingentLegalFees	1527000	USD
CY2015Q1	actg	Contingent Legal Fees ContingentLegalFees	4784000	USD
CY2014Q1	actg	Dividendsattributabletocommonstockholdersunderthetwoclassmethod Dividendsattributabletocommonstockholdersunderthetwoclassmethod	-6048000	USD
CY2015Q1	actg	Dividendsattributabletocommonstockholdersunderthetwoclassmethod Dividendsattributabletocommonstockholdersunderthetwoclassmethod	-6160000	USD
CY2014Q1	actg	Increase Decrease In Royalties And Contingent Legal Fees Payable IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable	-6552000	USD
CY2015Q1	actg	Increase Decrease In Royalties And Contingent Legal Fees Payable IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable	4778000	USD
CY2014Q1	actg	Litigation And Licensing Expenses Patents LitigationAndLicensingExpensesPatents	8994000	USD
CY2015Q1	actg	Litigation And Licensing Expenses Patents LitigationAndLicensingExpensesPatents	8675000	USD
CY2014Q1	actg	Patent Acquisition Costs Included In Accrued Expenses PatentAcquisitionCostsIncludedInAccruedExpenses	15250000	USD
CY2015Q1	actg	Patent Acquisition Costs Included In Accrued Expenses PatentAcquisitionCostsIncludedInAccruedExpenses	900000	USD
CY2014Q4	actg	Patents Accumulated Amortization PatentsAccumulatedAmortization	166565000	USD
CY2015Q1	actg	Patents Accumulated Amortization PatentsAccumulatedAmortization	179603000	USD
CY2014Q4	actg	Patents Net Of Accumulated Amortization PatentsNetOfAccumulatedAmortization	286636000	USD
CY2015Q1	actg	Patents Net Of Accumulated Amortization PatentsNetOfAccumulatedAmortization	274659000	USD
CY2014Q1	actg	Research Consulting And Other Expenses Business Development ResearchConsultingAndOtherExpensesBusinessDevelopment	992000	USD
CY2015Q1	actg	Research Consulting And Other Expenses Business Development ResearchConsultingAndOtherExpensesBusinessDevelopment	997000	USD
CY2014Q4	actg	Royalties And Contingent Legal Fees Payable RoyaltiesAndContingentLegalFeesPayable	14351000	USD
CY2015Q1	actg	Royalties And Contingent Legal Fees Payable RoyaltiesAndContingentLegalFeesPayable	19129000	USD
CY2014Q1	actg	Undistributed Earnings Loss Allocatedto Participating Securities Basic UndistributedEarningsLossAllocatedtoParticipatingSecuritiesBasic	0	USD
CY2015Q1	actg	Undistributed Earnings Loss Allocatedto Participating Securities Basic UndistributedEarningsLossAllocatedtoParticipatingSecuritiesBasic	0	USD
CY2014Q1	actg	Undistributed Earnings Loss Allocatedto Participating Securities Diluted UndistributedEarningsLossAllocatedtoParticipatingSecuritiesDiluted	0	USD
CY2015Q1	actg	Undistributed Earnings Loss Allocatedto Participating Securities Diluted UndistributedEarningsLossAllocatedtoParticipatingSecuritiesDiluted	0	USD
CY2015Q1	dei	Amendment Flag AmendmentFlag	false
CY2015Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2015Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015Q1	dei	Document Period End Date DocumentPeriodEndDate	2015-03-31
CY2015Q1	dei	Document Type DocumentType	10-Q
CY2015Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000934549
CY2015Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	51049566	shares
CY2015Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2015Q1	dei	Entity Registrant Name EntityRegistrantName	ACACIA RESEARCH CORP
CY2014Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	14860000	USD
CY2015Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	12705000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	20168000	USD
CY2015Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	30007000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-353000	USD
CY2015Q1	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-440000	USD
CY2015Q1	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P6Y
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	646595000	USD
CY2015Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	644404000	USD
CY2014Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14472000	USD
CY2015Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13038000	USD
CY2014Q4	us-gaap	Assets Assets	536348000	USD
CY2015Q1	us-gaap	Assets Assets	507364000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	218708000	USD
CY2015Q1	us-gaap	Assets Current AssetsCurrent	201780000	USD
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	58558000	USD
CY2015Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	53289000	USD
CY2014Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	58819000	USD
CY2015Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	53609000	USD
CY2013	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	2000	USD
CY2015Q1	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	3000	USD
CY2013	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	263000	USD
CY2015Q1	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	323000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	126685000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	133403000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	134466000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	101548000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	6718000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-32918000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.125
CY2015Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.125
CY2015Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.50
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2015Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50065382	shares
CY2015Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	51049566	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50065382	shares
CY2015Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	51049566	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	50000	USD
CY2015Q1	us-gaap	Common Stock Value CommonStockValue	51000	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-24450000	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13217000	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-24599000	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-13639000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1161000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1161000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	1161000	USD
CY2015Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	1161000	USD
CY2014Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14552000	USD
CY2015Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13101000	USD
CY2014Q1	us-gaap	Dividends Dividends	6255000	USD
CY2015Q1	us-gaap	Dividends Dividends	6375000	USD
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.51
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.51
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
CY2014Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.05
CY2015Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.01
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	54282000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	39191000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	38738000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	44368000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	48496000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	49584000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	274659000	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11693000	USD
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10575000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	30149000	USD
CY2015Q1	us-gaap	Goodwill Goodwill	30149000	USD
CY2014Q1	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	2565000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-25942000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13382000	USD
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1372000	USD
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	170000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	740000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2133000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7199000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9839000	USD
CY2014Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	2106000	USD
CY2015Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	0	USD
CY2014Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	62000	USD
CY2015Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	702000	USD
CY2014Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2015Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4355000	USD
CY2015Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5057000	USD
CY2015Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	10718000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	47300000	USD
CY2015Q1	us-gaap	Liabilities Liabilities	34145000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	536348000	USD
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	507364000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	45911000	USD
CY2015Q1	us-gaap	Liabilities Current LiabilitiesCurrent	32734000	USD
CY2014Q1	us-gaap	Licenses Revenue LicensesRevenue	12578000	USD
CY2015Q1	us-gaap	Licenses Revenue LicensesRevenue	34210000	USD
CY2015Q1	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.0115
CY2014Q4	us-gaap	Minority Interest MinorityInterest	5491000	USD
CY2015Q1	us-gaap	Minority Interest MinorityInterest	5069000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6165000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5437000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	33315000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11651000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20432000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15830000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-24421000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-13130000	USD
CY2014Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-149000	USD
CY2015Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-422000	USD
CY2014Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24628000	USD
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13345000	USD
CY2014Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-24628000	USD
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-13345000	USD
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	109000	USD
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	228000	USD
CY2014Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	38629000	USD
CY2015Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	47820000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-26051000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-13610000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	355000	USD
CY2015Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	355000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	0	USD
CY2015Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-28000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-447000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-84000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-476000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-143000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
CY2015Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
CY2014Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	0	USD
CY2014	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	426000	USD
CY2015Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	426000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	228000	USD
CY2015Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	250000	USD
CY2014Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	0	USD
CY2015Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-12000	USD
CY2014Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	6255000	USD
CY2015Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	6375000	USD
CY2014Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	14234000	USD
CY2015Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	13369000	USD
CY2014Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	987000	USD
CY2015Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	16861000	USD
CY2014Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	96000	USD
CY2015Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2015Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q1	us-gaap	Profit Loss ProfitLoss	-13552000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	500000	USD
CY2014Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	48632000	USD
CY2015Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	18579000	USD
CY2014Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	90000	USD
CY2015Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	938000	USD
CY2014Q1	us-gaap	Profit Loss ProfitLoss	-24570000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	421000	USD
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2015Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	10718000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-128095000	USD
CY2015Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-141225000	USD
CY2014Q1	us-gaap	Royalty Expense RoyaltyExpense	951000	USD
CY2015Q1	us-gaap	Royalty Expense RoyaltyExpense	9325000	USD
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4765000	USD
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3247000	USD
CY2014Q4	us-gaap	Short Term Investments ShortTermInvestments	58558000	USD
CY2015Q1	us-gaap	Short Term Investments ShortTermInvestments	53289000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	483557000	USD
CY2015Q1	us-gaap	Stockholders Equity StockholdersEquity	468150000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	489048000	USD
CY2015Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	473219000	USD
CY2014Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1729408	shares
CY2015Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	1729408	shares
CY2014Q4	us-gaap	Treasury Stock Value TreasuryStockValue	34640000	USD
CY2015Q1	us-gaap	Treasury Stock Value TreasuryStockValue	34640000	USD
CY2014Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2015Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48329375	shares
CY2015Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49212207	shares
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48329375	shares
CY2015Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49212207	shares
CY2015Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentrations. </font><font style="font-family:inherit;font-size:10pt;">Two licensees individually accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">58%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the three months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;text-decoration:none;">March 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, and one licensee accounted for </font><font style="font-family:inherit;font-size:10pt;">39%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the three </font><font style="font-family:inherit;font-size:10pt;">months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2014</font><font style="font-family:inherit;font-size:10pt;">. Two licensees individually represented approximately </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">66%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">17%</font><font style="font-family:inherit;font-size:10pt;"> of accounts receivable at </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;text-decoration:none;">March 31, 2015</font><font style="font-family:inherit;font-size:10pt;">. Three licensees individually represented approximately </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">30%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">17%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;"> of accounts receivable at December 31, 2014. For the three </font><font style="font-family:inherit;font-size:10pt;">months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">March 31, 2015</font><font style="font-family:inherit;font-size:10pt;"> and 2014, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">62%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">16%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. The Company does not have any material foreign operations.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>
CY2015Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates.  </font><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, stock-based compensation expense, impairment of marketable securities and intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets and the application of the acquisition method of accounting for business combinations, require its most difficult, subjective or complex judgments.</font></div></div>

Files In Submission

Name	View Source	Status
0000934549-15-000013-index-headers.html	Edgar Link	pending
0000934549-15-000013-index.html	Edgar Link	pending
0000934549-15-000013.txt	Edgar Link	pending
0000934549-15-000013-xbrl.zip	Edgar Link	pending
actg-20150331.xml	Edgar Link	completed
actg-20150331.xsd	Edgar Link	pending
actg-20150331_cal.xml	Edgar Link	unprocessable
actg-20150331_def.xml	Edgar Link	unprocessable
actg-20150331_lab.xml	Edgar Link	unprocessable
actg-20150331_pre.xml	Edgar Link	unprocessable
actg10q03312015.htm	Edgar Link	pending
ex31103312015.htm	Edgar Link	pending
ex31203312015.htm	Edgar Link	pending
ex32103312015.htm	Edgar Link	pending
ex32203312015.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
graphicactga02.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACTG
ACACIA RESEARCH CORP Stock $actg

2015 Q1 Form 10-Q Financial Statement

#000093454915000013 Filed on May 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACTG ACACIA RESEARCH CORP Stock $actg

2015 Q1 Form 10-Q Financial Statement

#000093454915000013 Filed on May 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACTG
ACACIA RESEARCH CORP Stock $actg